학술논문
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study
Document Type
Article
Author
Lau, George; Benhamou, Yves; Chen, Guofeng; Li, Jin; Shao, Qing; Ji, Dong; Li, Fan; Li, Bing; Liu, Jialiang; Hou, Jinlin; Sun, Jian; Wang, Cheng; Chen, Jing; Wu, Vanessa; Wong, April; Wong, Chris L P; Tsang, Stella T Y; Wang, Yudong; Bassit, Leda; Tao, Sijia; Jiang, Yong; Hsiao, Hui-Mien; Ke, Ruian; Perelson, Alan S; Schinazi, Raymond F
Source
In The Lancet Gastroenterology & Hepatology October 2016 1(2):97-104
Subject
Language
ISSN
2468-1253